Kenvue (KVUE, Personal Care Products) Stock Valuation & Fair Value Fairly valued
Kenvue (KVUE, Personal Care Products) trades at a blended P/E of 16.8, about 2% below its historical normal valuation, with a forward growth estimate of 6.9% and a PEG of 2.43. Analysts' one-year estimates have been hit 50% of the time.
The Street vs SeerForecast
Wall Street's mean price target for KVUE is $19.50 across 12 analysts, 2.3% above the current price. The average analyst rating is Hold. Our SeerForecast read of the same stock, formed without analyst targets: fairly valued. When the two disagree, start your digging there.
Valuation flags
- No notable valuation flags.
Verdict history
tickerseer's rating has been fairly valued since 2026-06-03.
Not every point was recorded live. Points marked recalculated apply today's valuation rules to the metrics tickerseer archived that week.
Frequently asked questions
Is Kenvue stock overvalued?
At a blended P/E of 16.8 versus its historical normal P/E of 17.1, Kenvue trades about 2% below its typical valuation, with a PEG of 2.43 on 6.9% forward growth. tickerseer currently rates it fairly valued.
What is Kenvue's fair value and PEG?
Kenvue trades at a blended P/E of 16.8 against a historical normal P/E of 17.1, a PEG of 2.43, and a forward growth estimate of 6.9%.
Has tickerseer's rating of Kenvue changed?
tickerseer's rating has been fairly valued since 2026-06-03.
What is the analyst price target for Kenvue?
The mean Wall Street price target for Kenvue is $19.50 across 12 analysts, 2.3% above the current price. tickerseer's SeerForecast verdict is formed independently of analyst targets.
Industry: Personal Care Products. Create a free account to see the full analysis: the SeerAI score, its five quality sub-scores, valuation history, and the AI research note. Options setups and metric history are part of the paid plans.
Get the free weekly earnings preview
One email each Monday with the week's named earnings setups, the reasoning, and what settled last week. Strikes and sizing stay in Premium.
It's free, and you can unsubscribe any time. Educational content, not investment advice.